Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/29/2010CN101167805B Use of medicinal composition containing lotus leaves and hypericum japonicum total flavone extraction in preparing medicine for hepatitis B virus
12/29/2010CN101166740B Imidazo (1,2-a) pyridine derivatives useful as peptide deformylase (PDF) inhibitors
12/29/2010CN101160354B Polymeric pharmaceutical agent for treatment of cancer and process for production of the same
12/29/2010CN101160130B Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
12/29/2010CN101146523B Transdermal delivery systems
12/29/2010CN101142193B Propane-1,3-dion derivative or salt thereof
12/29/2010CN101130063B Segmented intestine targeted preparation of orgotein polypeptide and method of preparing the same
12/29/2010CN101117348B A and C macrocyclic oxidation substituted pentacyclic triterpanoids and preparation method and use thereof
12/29/2010CN101103029B 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents
12/29/2010CN101098702B Drugs, food or drink for improving pancreatic functions
12/29/2010CN101087606B Estrogen receptor modulators
12/29/2010CN101057661B Extraction method for alpha-linolenic acid and preparation
12/29/2010CN101052400B Application of pyridine compound for preparing medicine for curing injured skin
12/29/2010CN101028280B Lavage liquor preparation for operation and its production
12/29/2010CA2803330A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
12/29/2010CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010CA2781865A1 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
12/29/2010CA2781771A1 Method for treatment of diseases
12/29/2010CA2767708A1 Cross-linked polyallylamine tablet core
12/29/2010CA2766809A1 Protease inhibitors, compositions and methods of use
12/29/2010CA2766696A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010CA2766642A1 Compounds and methods for treating influenza
12/29/2010CA2766632A1 Enantiomeric compositions of 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one and related methods
12/29/2010CA2766618A1 Polymorphic form d of bazedoxifene acetate and methods of preparing same
12/29/2010CA2766550A1 Benzamide derivatives
12/29/2010CA2766524A1 Method for treating a patient in need of aspirin therapy
12/29/2010CA2766508A1 Applicator for applying a product to hair
12/29/2010CA2766387A1 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
12/29/2010CA2766354A1 Topical composition containing ibuprofen
12/29/2010CA2766320A1 Acid-labile trigger units
12/29/2010CA2766291A1 Injectable formulations containing asenapine and method of treatment using same
12/29/2010CA2766197A1 Pharmaceutical composition for emergency contraception
12/29/2010CA2766193A1 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
12/29/2010CA2766154A1 Novel fumarate salts of a histamine h3 receptor antagonist
12/29/2010CA2766151A1 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use
12/29/2010CA2766107A1 A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
12/29/2010CA2766106A1 Use of derivatives of indoles for the treatment of cancer
12/29/2010CA2766104A1 Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
12/29/2010CA2766088A1 Heterocyclic compounds for the treatment of neurological and psychological disorders
12/29/2010CA2766048A1 Novel acetylsalicylic acid salts
12/29/2010CA2766033A1 Prodrugs of nh-acidic compounds
12/29/2010CA2766002A1 Efficient isolation of cimiracemate a, and methods of use
12/29/2010CA2765997A1 Treatment of endometriosis
12/29/2010CA2765988A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/29/2010CA2765985A1 5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors
12/29/2010CA2765983A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
12/29/2010CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity
12/29/2010CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity
12/29/2010CA2765817A1 Heterocyclic compounds and their uses
12/29/2010CA2765815A1 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
12/29/2010CA2765734A1 Implantable drug delivery devices and methods of making the same
12/29/2010CA2765697A1 Diffusion enhancing compounds and their use alone or with thrombolytics
12/29/2010CA2765692A1 Novel azabicyclohexanes
12/29/2010CA2765678A1 Substituted hydroxamic acids and uses thereof
12/29/2010CA2765635A1 Pharmaceutical composition of duloxetine or pharmaceutically acceptable salts thereof
12/29/2010CA2765630A1 Solid drug tablets for implantable drug delivery devices
12/29/2010CA2765527A1 N-substituted-cyclic amino derivative
12/29/2010CA2765462A1 Mexiletine amino acid and peptide prodrugs and uses thereof
12/29/2010CA2764963A1 Method for treating a patient at risk for developing an nsaid-associated ulcer
12/29/2010CA2764956A1 Novel biphenyl and phenyl-pyridine amides
12/29/2010CA2764665A1 Compositions for treating drug addiction and improving addiction-related behavior
12/29/2010CA2764597A1 Therapeutic drug for hypertension or high-normal blood pressure
12/29/2010CA2764526A1 The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer
12/29/2010CA2764475A1 Crystals
12/29/2010CA2764423A1 Preparation comprising insulin, nicotinamide and an amino acid
12/29/2010CA2764060A1 Topical compositions and methods for wound care
12/29/2010CA2763766A1 3-substituted-8-substituted-3h-imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
12/29/2010CA2762675A1 Heterocyclic antiviral compound
12/29/2010CA2761921A1 Novel indole, indazole and benzimidazole arylamides
12/29/2010CA2761427A1 A pharmaceutical composition
12/29/2010CA2754654A1 Novel oxazolone and pyrrolidinone-substituted arylamides
12/29/2010CA2752865A1 Quickly soluble oral film dosage containing steviosides as a unpleasant taste masking agent
12/29/2010CA2698513A1 Micronized progesterone-based pharmaceutical composition and its uses
12/28/2010USRE42015 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
12/28/2010USRE42014 Pharmaceutical compositions
12/28/2010USRE42012 Compositions and methods for enhancing receptor-mediated cellular internalization
12/28/2010US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them
12/28/2010US7858820 Easy to process and are highly stable on storage; nutraceuticals; dietetics; anions of inner salts contribute to therapeutic and nutritional value of compound; human and animal food/feed supplement; dosage
12/28/2010US7858807 reacting an N-substituted amidine compound or a salt thereof with a ketone compound, in the presence of a base; cyclization; efficiency
12/28/2010US7858806 hydrolyzing the brominated product of 1-methylhydantoin to form 5-hydroxy-1-methylimidazolidin-2,4-dione, drug such as for renal failure; purified product for renal patients
12/28/2010US7858800 Biaryl derivatives
12/28/2010US7858797 Biphenyl compounds useful as muscarinic receptor antagonists
12/28/2010US7858795 or anticholinergic agents such as biphenyl-2-ylcarbamic acid 1-[2-({6-[(4-hydroxybenzylamino)methyl]pyridin-2-ylmethyl}carbamoyl)ethyl]piperidin-4-yl ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma
12/28/2010US7858794 such as 5-Chloro-thiophene-2-carboxylic acid (1-acetyl-7-dimethylamino-4-methyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide, having follicle stimulating hormone modulatory activity, used to regulate fertility as contraceptives and for treatment of breast cancer, prostate cancer and endometriosis
12/28/2010US7858792 Biphenyl-2-ylcarbamic Acid 1-(2-{5-[2-(4-Hydroxyphenyl)ethylamino]pentylcarbamoyl}ethyl)piperidin-4-yl Ester, used for the treatment of respiratory system disorders such as chronic obstructive pulmonary disease and asthma
12/28/2010US7858789 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines
12/28/2010US7858786 Pyrimidines and pyrazines useful as modulators of ion channels
12/28/2010US7858785 1-(2-{5-Chloro-4-[5-(4-fluoro-phenylimino)-4-methyl-4,5-dihydro-[1,3,4]thiadiazol-2-yl]-pyrimidin-2-ylamino}-ethyl)-5,5-dimethyl-imidazolidine, useful for treating diseases mediated by polo-like kinase 1, such as rheumatoid arthritis and breast cancer; antiproliferative agents
12/28/2010US7858782 e.g. N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide; protein (tyrosine and serine/threonine) kinase inhibitor; variety of conditions and diseases; antiproliferative, anticarcinogenic, antiinflammatory, antiallergenic agent; autoimmune and neurodegenerative disorders
12/28/2010US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
12/28/2010US7858774 Synthesis of 5-azacytidine
12/28/2010US7858666 IRE-1α inhibitors
12/28/2010US7858665 1-[4-(nitrooxymethyl)benzoylaminomethyl]-cyclohexaneacetic acid; neurophatic pain
12/28/2010US7858664 Contacting cells with a zinc-binding compounds, having effective amount of carboxylic acid derivative or hydroxamic acid derivative inhibitor compound; treating cancer, blood disorders, genetic related metabolic disorders; 3-methyl-5-phenyl-2,4-pentadienoic acid
12/28/2010US7858663 Physical and chemical properties of thyroid hormone organic acid addition salts
12/28/2010US7858662 Medicament for the treatment of viral skin and tumour diseases
12/28/2010US7858661 Protein refolding agent and refolding method
12/28/2010US7858660 oral administering a drug mixture of amantadine, rimantadine, and ribavirin or viramidine, and a neuraminidase inhibitor such as oseltamivir, zanamivir, or peramivir; viral disease treatment
12/28/2010US7858659 Redox therapy for tumors
12/28/2010US7858658 5'-chloro-N-[3,3,3-trifluoro-2-(trifluoromethyl)-1S-(hydroxymethyl)propyl]thiophene-2'-sulfonamide, used for the treatment of Alzheimer's Disease and Down's syndrome
1 ... 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 ... 7860